Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
November 2017—Beckman Coulter Life Sciences has introduced DuraClone RE antibody panels for the detection of rare, abnormal events in blood disorders. The panels provide tools to study low frequency populations of abnormal CD5+ B cells (RE CLB), abnormal plasma cells (RE PC), or abnormal B progenitor cells (RE ALB).
November 2017—Mologic (Thurleigh, U.K.) received CE marking for its BVPro, a 15-minute point-of-care diagnostic that detects sialidase enzyme activity from a vaginal swab sample.
November 2017—iBio has partnered with TheoremDx to develop proteins for rapid diagnostic testing products. The collaboration will leverage the TheoremDx point-of-care diagnostic system and the protein development and manufacturing capabilities
November 2017—Molecular diagnostic device company iCubate has earned FDA clearance for its iCubate platform, the iC-System, and its first clinical assay, the iC-GPC Assay, used for the rapid detection of pathogenic bacteria associated with bloodstream infection.
November 2017—MilliporeSigma launched its Milli-Q HR 7000 series, a high-throughput water purification system that offers a uniquely connected and sustainable central pure water solution. The system ensures constant water quality and flow rate while reducing water consumption and running costs, as compared with other high-throughput reverse osmosis systems, and produces up to 13,000 liters of pure water daily.
November 2017—Quantimetrix announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for the company’s Dipper POCT Urinalysis Control. The patent application is directed to a liquid holding apparatus for insertion of a test device into a test liquid. The invention includes various technical innovations relating to the formation and use of an in vitro diagnostic pouch device.
November 2017—Denka Seiken has received FDA 510(k) clearance for its small, dense LDL cholesterol (sdLDL-C) assay, designed for use with automated chemistry analyzers.
November 2017—Binding Site’s Immunologicals Group has added two varicella zoster virus antigens to its line of products for in vitro diagnostic manufacturing and research applications. Both the standard VZV antigen and the VZV glycoprotein antigen have been designed for use as integral components within solid phase enzyme immunoassay test procedures.
November 2017—Aquaro Histology exhibited its AquaroASM, the company’s device for automating microtomy, at the 43rd Annual National Society for Histotechnology Symposium/Convention in September.
October 2017—Insight Pharma Reports has published Commercializing Novel IVDs: A Comprehensive Manual for Success by Harry Glorikian, MBA, who has more than 30 years in the global IVD field and in IVD innovation.
